Clinical Oncology Week articles from October 2004

Clinical Oncology Week archives from October 2004

Chromosomal translocations involving 6p22 breakpoint identified.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Novel chromosomal translocations in acute myeloid leukemia (AML) have been identified and characterized. "The detection of chromosomal aberrations is essential for the diagnosis and therapy" of...

Noninvasive breast fluid tests aim to detect disease at most treatable stage.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Two companies are participating in the race to develop a screening technique for early-stage breast cancer based on testing breast fluid. IMI International Medical Innovations, Toronto, Canada, has...

Five dose levels of monoclonal antibody melanoma vaccine compared.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Researchers report the results of a phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside in a recent issue of the journal Vaccine. ...

"Hedgehog" signal distinguishes lethal from localized prostate tumors.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Johns Hopkins researchers have discovered a possible way to distinguish lethal metastatic prostate cancers from those restricted to the walnut-size organ. If future studies show their test -...

Allogenic SCT patients have more fatigue compared with autologous SCT patients.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Allogeneic stem cell transplant patients have more fatigue compared with autologous stem transplant patients at 3 years. According to recent research from Norway, "Health-related quality of life...

Animal models are guiding development of new immunotherapies for cancer.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Animal models are guiding the development of new immunotherapies for cancer. According to recent research published in the Journal of Leukocyte Biology, "Immunotherapy using adoptive cell transfer...

Decoupling the control of brain cancer cells may lead to better treatments.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- When he's not in the operating room performing surgery, Donald M. O'Rourke, MD, associate professor of neurosurgery at the University of Pennsylvania School of Medicine is fighting brain tumors from the...

European marketing authorization issued for expanded use of Gliadel Wafer.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Guilford Pharmaceuticals Inc. (GLFD) announced that its proprietary treatment for brain cancer, Gliadel Wafer (polifeprosan 20 with carmustine implant), has been granted extended marketing authorization...

Brachytherapy applicator introduced for treating early-stage disease.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Varian Medical Systems (NYSE: VAR) announced the introduction of a new lightweight applicator for delivering postlumpectomy partial breast irradiation. The Advanced Breast Template System for...

New test discovers breast cancer at early, most treatable stage.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Doctors may soon have a new tool - a noninvasive, painless nipple fluid test - in their fight to make breast cancer a more treatable, nonfatal disease. Within the next couple years, women will be...

MastaScope Mammary Ductoscopy System to be distributed in China.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Lifeline Biotechnologies, Inc., (LBTT) has entered into a 4-year contract with International Medical Consulting Group (IMCG) of Dallas, Texas, for its Chinese company, Shanghai Science Medical...

"Pill camera" to be developed to detect cancer, monitor body functions.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Infotonics Technology Center and Medi-photonics Development Company LLC announced their intent to agree to jointly develop the Compact Photonic Explorer (CPE), or "pill camera," for medical and...

MMA may result in 43%-54% loss in community-based cancer care funds in 2005.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- At a Congressional briefing on Capitol Hill, the American Society of Clinical Oncology (ASCO) released findings from an analysis of the effect of the Medicare Modernization Act (MMA) on cancer care in...

Double drug combo attacks tumor and blood vessel development.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cancer researchers have long suggested that new targeted drugs may work best when paired with other therapies. In a new study published in Cancer Research, scientists have taken some of the first...

Companies initiate phase IIIb clinical trial of Tarceva in advanced NSCLC.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Genentech, Inc., (DNA) and OSI Pharmaceuticals, Inc., (OSIP) announced the initiation of a phase IIIb clinical study of the investigational therapy Tarceva (erlotinib HCl) in patients with second- and...

Use of iron deficiency test as colorectal cancer screen feasible.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The use of an iron deficiency test as a colorectal cancer screen is feasible, although the benefit may be marginal. "Iron deficiency is common at presentation in colorectal cancer," physicians in...

Colorectal neoplasm preoperative tattooing reliable for laparoscopic resection.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Researchers from New York City reported that preoperative endoscopic tattooing of colorectal neoplasms is generally a safe and reliable method of tumor localization in laparoscopic resection. ...

Minimal residual disease assessment predicts survival and relapse in AML.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Minimal residual disease assessment predicts survival and relapse in acute myeloid leukemia. "Outgrowth of minimal residual disease (MRD) in acute myeloid leukemia (AML) is responsible for the...

Vaginal, cervical cancer differentiated by cluster analysis of protein patterns.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cluster analysis of proteomics data differentiates among normal vaginal mucosa, primary vaginal and primary cervical cancer "Protein patterns in six samples from primary vaginal cancers, in five...

Collaboration agreement signed for development of non-antibody protein.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Nautilus Biotech SA and Creabilis Therapeutics SRL signed a collaboration agreement for the identification and development of an improved variant of CT500, a non-antibody protein selected by Creabilis...

Tumor-specific gene therapy targets uterine cervical cancer.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Tumor-specific gene therapy targets uterine cervical cancer. According to published research from South Korea, "although gene therapies using tissue-specific promoters have been reported to be a...

Gynecologic Cancer Foundation releases report on detection, treatment advances.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The Gynecologic Cancer Foundation (GCF) released the "State of the State of Gynecologic Cancers - Second Annual Report to the Women of America." The report details the most recent advances in the...

HIV specialists and oncologists differ in pain management and palliative care.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- HIV specialists and oncologists differ in their opinions of pain management and palliative care. "Despite the introduction of HAART, pain is still a common symptom in people living with HIV/AIDS....

An excellent response to BNCT treatment seen.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A Finnish research group has been the first in the world to publish an article in which boron neutron capture therapy (BNCT) treatment has had an excellent response in a patient with head and neck...

Head and neck cancer brochure helps patients understand treatment.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- To help patients understand the importance of radiation therapy in the treatment of head and neck cancer, the American Society for Therapeutic Radiology and Oncology has published the new patient...

Small bowel intraepithelial lymphocytes isolated using magnetic beads.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Scientists have isolated human small bowel intraepithelial lymphocytes using Annexin V-coated magnetic beads. "Human intestinal intraepithelial lymphocytes (IEL) are important effector cells of the...

Multikine immunotherapy drug lowers cholesterol in cancer study patients.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corporation (CVM) announced that its investigational immunotherapy drug Multikine has been shown to lower cholesterol in clinical studies involving 120 head and neck cancer patients. In...

Discovery of biological principle could lead to better cancer treatment.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Pioneering research on leukemia cells has identified their vulnerable spot. This new knowledge can now be used to produce more effective medicines. A group of scientists at the University of Bergen...

Tumor genes cluster into two subsets that correlate to survival.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- An analysis of the gene expression patterns of 91 unrelated liver tumors revealed two distinctive subclasses highly associated with patient survival, according to a new study. The study is among...

Anticancer drug HGS-ETR1 advances to phase II clinical development.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced that it has begun dosing patients in a phase II clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with...

Further classification of lung tumors may better predict survival.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- A new study suggests that further categorization of stage IA lung cancer tumors would better aid in prediction of an individual's chances of survival than the currently used classification of whether a...

Mobetron manufacturer and distributor to be acquired.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Intraop Medical Corporation (IOPM) announced that Shamy, the holder of record of 20,000,000 shares of the company's common stock, representing 89.75% of the company's outstanding 22,284,000 shares of...

Early intensive therapy beneficial for primary resistant myeloma patients.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Early intensive therapy is beneficial in patients with primary resistant myeloma. "Clinical outcomes were evaluated in 89 consecutive patients with multiple myeloma that had not responded to...

Novel target found for detecting ovarian cancer in blood.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Scientists have discovered a new way to detect ovarian cancer in the blood. Reporting in the September 15, 2004, issue of Cancer Research, Fox Chase Cancer Center, Philadelphia, researchers explain...

Cyst fluid analysis useful for differential diagnosis of pancreatic cysts.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Researchers from South Korea reported in Diagnostic Cytopathology that cyst fluid analysis is useful for the differential diagnosis of pancreatic cysts. Y.T. Kim and colleagues wrote, "Pancreatic...

Biopharmaceutical company announces appointment of chief financial officer.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Lorus Therapeutics Inc. announced the appointment of Paul J. Van Damme as chief financial officer. Van Damme has more than 20 years of financial strategy and operations experience in the...

Report links elevated levels of hedgehog signaling to metastatic prostate cancer.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Curis, Inc., (CRIS) announced that the online issue of the scientific journal Nature contains a report demonstrating that abnormally elevated levels of Hedgehog pathway activity are a distinguishing...

Group therapy doesn't improve survival in patients with early-stage breast cancer.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- A new study shows that cognitive-existential group therapy (CEGT), a psychosocial intervention designed to improve the mood and attitude of patients with breast cancer, does not improve survival of...

Ganoderma lucidum spore extract may possesses antiangiogenic properties.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Ganoderma lucidum spore extract may possesses antiangiogenic properties. "This study was conducted to investigate the anti-proliferative activities of medicinal mushroom Ganoderma lucidum (Rei-shi...

Membrane-bound peptidases are diagnostic markers for gynecological cancers.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Membrane-bound peptidases are diagnostic markers for gynecological cancers. "Membrane-bound peptidases play a key role in the control of growth, differentiation, and signal transduction of many...

Angiogenic markers are among factors that can predict liver cancer recurrence.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Angiogenic markers are among factors that can predict liver cancer recurrence. "Molecular markers (biomarkers) for hepatocellular carcinoma (HCC) metastasis and recurrence could provide additional...

Surveillance is mandatory after hepatocellular carcinoma and MOVC resection.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Surveillance is mandatory after hepatocellular carcinoma and MOVC resection. "We report a 54-year-old Japanese woman who developed liver tumors 102 months after hepatic resection for hepatocellular...

Collaboration to develop fully human antibody therapeutics for cancer.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) and diaDexus, Inc., announced an expansion of their existing collaboration for the research and development of fully human antibody therapeutics against novel cancer targets...

Antioxidant intervention protective against oxidative DNA damage.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Antioxidant intervention is protective against oxidative DNA damage. According to a review published in the journal Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, "Cells...

VIOXX maker withdraws drug from market.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Merck &. Co., Inc. has announced a voluntary worldwide withdrawal of VIOXX (rofecoxib), its arthritis and acute pain medication. The company's decision, which was effective September 30, 2004, is...

Biological markers may aid in early detection of asbestos-related diseases.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Researchers from Poland reported that biological markers, including tissue polypeptide antigen, may aid in the early detection of asbestos-related diseases in at-risk individuals. "Asbestos has...

Dogs can "smell" bladder cancer.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Dogs can be trained to detect bladder cancer by "smelling" urine, concludes new research from Amersham Hospital, Amersham, England. Tumors are thought to produce volatile organic compounds with...

Characteristic oligodendroglioma genes identified.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Several gene expression patterns characteristic of oligodendrogliomas have been identified. According to oncologists in France, the "histological diagnosis of low-grade astrocytomas and...

Company's lead cancer compound shown to cross blood-brain barrier.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Ecopia BioSciences, Inc., (EIA) has obtained results demonstrating that its lead compound ECO-4601, a drug candidate to treat brain cancer, crosses the blood-brain barrier. This new data, coupled...

Eradication of brain tumor in lab model holds promise for treatment in humans.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Results of an academic-industry partnership study demonstrate that targeting a single protein in the hedgehog pathway can block growth of cancer cells The eradication of brain tumors in mice...

Agreement enables use of CellSearch Circulating Tumor Cell Kit.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Immunicon Corporation (IMMC) has entered into an agreement with Quest Diagnostics, Incorporated, (DGX) for the purchase of the Immunicon CellTracks AutoPrep System and the Immunicon CellSpotter...

CAD improves MRI specificity.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- A recent study published in the New England Journal of Medicine provided strong evidence that breast magnetic resonance imaging exams can be effective in finding tumors in women at high risk for breast...

Eating more soy-rich foods could reduce metastasis.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Eating more soy-rich foods could reduce the spread of breast cancer, suggest results of a new study from the University of Ulster. Pamela Magee has been investigating the effects of a group of...

FDA clears next generation 5-day internal radiation therapy device.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Proxima Therapeutics, Inc. has received marketing clearance from the U.S. Food and Drug Administration (FDA) for the next generation of its MammoSite balloon catheter device. The latest version of...

Foundation offers free wellness and image booklet for women with cancer.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Can you imagine what it would be like to have all your hair fall out in the shower? Or to wake up with no eyebrows or eyelashes? For thousands of women undergoing chemotherapy in 2004, this is a...

HDCT in chemosensitive and de novo metastatic breast cancer safe/well tolerated.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- High dose chemotherapy in chemosensitive, de novo metastatic breast cancer is safe and well-tolerated. According to recent research from Israel, "The prognosis of patients with de novo stage IV...

Immediate breast reconstruction after mastectomy doesn't delay chemotherapy.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- A recent study found an increased risk of wound complications in patients who underwent breast reconstruction directly after mastectomy, but also that the procedure did not delay the initiation of...

MRI accurately detects remaining cancer after lumpectomy.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Magnetic resonance imaging (MRI) accurately detects remaining cancer after lumpectomy, study results indicate. "Specialists counseling women at genetically increased risk for developing breast...

Prophylactic mastectomy study patients satisfied with breast reconstruction.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Researchers from the University of Toronto, Canada, reported in Plastic and Reconstructive Surgery that the majority of study participants who underwent breast reconstruction after prophylactic...

Study shows bilateral breast carcinoma local recurrence from ipsilateral tumor.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Researchers from Austria report evidence of local recurrence of bilateral breast carcinoma most often from the ipsilateral tumor. S.F. Lax and colleagues reported in Modern Pathology, "Local...

Genomics company announces new organizational structure.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- NeoGenomics, Inc., (BULLETIN BOARD: NGNM) announced that it is reorganizing the operations of the company into four distinct operating divisions to better reflect its business offerings. Clinical...

Antisense anti-cancer drug candidate licensed to Lilly for clinical development.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Isis Pharmaceuticals, Inc., (ISIS) announced that Eli Lilly and Company (LLY) licensed LY2275796, a second-generation antisense anti-cancer drug candidate for clinical development. LY2275796...

Cancer research presented at meeting in Atlanta.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- The American Society for Therapeutic Radiology and Oncology held its 46th Annual Scientific Meeting at the Georgia World Congress Center in Atlanta, Georgia. Nearly 10,000 top cancer doctors and...

Group forms to test new cancer drugs in children.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- University of Florida (UF) physicians have partnered with eight other academic medical centers to form a national consortium aimed at testing new cancer therapies in children who fail to respond to...

New anti-inflammatory strategy for cancer identified.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- A new strategy for cancer therapy, which converts the tumor-promoting effect of the immune system's inflammatory response into a cancer-killing outcome, is suggested in research findings by...

Antigen Express tests melanoma vaccine with Fred Hutchinson clinician.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced that its wholly owned subsidiary, Antigen Express, has entered into a collaboration with Dr. Cassian Yee of the Fred Hutchinson Cancer Research Center,...

Immunoglobulin V[subscript]H peptides provoke tumor-specific immune response.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Germ line tumor-associated immunoglobulin V[subscript]H region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells. "Previous studies have...

Vaccinia virus expressing lymphoid chemokine elicits antitumor response.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell-dependent antitumor response. According to recent research published in the...

Double-dealing receptor protein on tumors promotes cancer development in nucleus.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Texas M.D. Anderson Cancer Center now have evidence that receptors found on tumors that were believed to function only on the surface of cells can actually switch on...

HPV testing in cervical cancer screening highlighted at pathology meeting.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- The emerging role of human papillomavirus (HPV) testing as a standard of care in cervical cancer screening was highlighted at the annual meeting of the College of American Pathologists (CAP) in...

Pharmaceutical company begins clinical trial for cervical cancer treatment.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- OXiGENE, Inc., (NASDAQ: OXGN, XSSE: OXGN) announced that its lead compound, Combretastatin A4 Prodrug (CA4P), will enter into a phase I clinical trial in combination with cisplatin for cervical cancer....

Beta-catenin expression related to pit pattern in colorectal cancer.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Beta-catenin expression is associated with pit pattern in colorectal cancer. "To investigate the usefulness of pit pattern to estimate depth of submucosal invasion and the mechanism of change in...

Newsletters, videos might cut cancer in churchgoing blacks.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Combining newsletters individually customized to the health status and lifestyle of the people reading them, along with culturally tailored educational videotapes, might help prevent colorectal cancer...

Curcumin alters prostate cancer cell motility and microfilament organization.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Curcumin alters prostate cancer cell motility and microfilament organization. "Curcumin is a dietary phytochemical associated with anti-tumorigenic effects, but the mechanisms by which it inhibits...

Gynecologic Cancer Foundation position clarified.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- The following statement was received from the Gynecologic Cancer Foundation. "The Gynecologic Cancer Foundation (GCF) has become aware of a news summary published by NewsRx.com and its related...

Licensing agreement to facilitate development of imaging agents for diagnostics.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Kereos and The Dow Chemical Company (DOW) entered into a licensing agreement to allow both companies access to patent portfolios for the development and commercialization of targeted imaging agents....

Targeting stress response proteins on breast, prostate tumor cells shows promise.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Stress response proteins present on the outside of cancer cells offer a promising target for a novel drug "guidance system," say researchers at the University of Texas M.D. Anderson Cancer Center. ...

"Cure" a 4-letter word for cancer doctors.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- At a time when more people are cured of cancer than ever before, fewer doctors seem willing to say so. They call the cancer undetectable, or in remission. They tell patients they can quit seeing cancer...

Researchers discover a "link" in tumor growth.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- To develop new therapeutic approaches to cancer, it is essential to understand the long and extremely complex process that underlies it; in other words, the various stages of cancer development from...

$7.5 million grant awarded to study role of viruses in cancer.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- The U.S. National Cancer Institute recently awarded a 5-year, $7.5 million program project grant to investigators at the Yale School of Medicine to continue studies on the role of viruses and mutant...

Higher dose of Glivec improves progression-free survival in GIST study patients.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Patients in a study taking an 800-mg daily dose of Glivec (imatinib) for treatment of certain forms of gastrointestinal stromal tumor (GIST) had significantly longer progression-free survival compared...

Twice daily imatinib could improve outcome.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Results of a new randomized trial suggest that a single daily 400 mg dose of imatinib - known to be a first-choice treatment for gastrointestinal stromal tumors (GIST) - is sufficient to induce a...

Researchers report on approaches for end-of-life care in gynecologic oncology.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- Researchers from the University of Texas reported on gynecologic oncologists' approaches and opinions regarding end-of-life care for gynecologic oncology patients. "We sought to explore the...

Recent development in human papillomavirus vaccines reviewed.
October 11, 2004... 2004 OCT 11 - (NewsRx.com & NewsRx.net) -- A researcher reviews recent development in human papillomavirus vaccines in a recent issue of Expert Opinion on Investigational Drugs. According to a study from England, "The association of certain...